Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
6
×
investing
6
×
life sciences
national blog main
boston blog main
deals
san francisco blog main
boston top stories
national top stories
new york blog main
san diego blog main
san diego top stories
san francisco top stories
startups
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
detroit blog main
detroit top stories
drugs
eli lilly
indiana blog main
indiana top stories
national
new york top stories
nonalcoholic steatohepatitis
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
astrazeneca
boston
What
drug
6
×
fda
medicines
roundup
annual
approved
attention
bio
biotech
cancer
disease
therapeutics
affects
ahead
alzheimer’s
ambien
american
americans
approval
asco
assessed
attendees
bacteria
biopharma
blueprint
business
camp’s
candidate
cash
chicago
city
clinical
combinations
communities
community’s
companies
company
conference
currently
date
Language
unset
Current search:
investing
×
drug
×
fda
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
